1. Home
  2. PHAR vs CYH Comparison

PHAR vs CYH Comparison

Compare PHAR & CYH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHAR
  • CYH
  • Stock Information
  • Founded
  • PHAR 1988
  • CYH 1985
  • Country
  • PHAR Netherlands
  • CYH United States
  • Employees
  • PHAR N/A
  • CYH N/A
  • Industry
  • PHAR Biotechnology: Pharmaceutical Preparations
  • CYH Hospital/Nursing Management
  • Sector
  • PHAR Health Care
  • CYH Health Care
  • Exchange
  • PHAR Nasdaq
  • CYH Nasdaq
  • Market Cap
  • PHAR 627.5M
  • CYH 623.8M
  • IPO Year
  • PHAR N/A
  • CYH 1991
  • Fundamental
  • Price
  • PHAR $9.67
  • CYH $2.92
  • Analyst Decision
  • PHAR Strong Buy
  • CYH Hold
  • Analyst Count
  • PHAR 3
  • CYH 6
  • Target Price
  • PHAR $27.00
  • CYH $4.40
  • AVG Volume (30 Days)
  • PHAR 5.8K
  • CYH 2.4M
  • Earning Date
  • PHAR 03-13-2025
  • CYH 02-18-2025
  • Dividend Yield
  • PHAR N/A
  • CYH N/A
  • EPS Growth
  • PHAR N/A
  • CYH N/A
  • EPS
  • PHAR N/A
  • CYH N/A
  • Revenue
  • PHAR $285,745,000.00
  • CYH $12,551,000,000.00
  • Revenue This Year
  • PHAR $20.08
  • CYH $1.16
  • Revenue Next Year
  • PHAR $9.22
  • CYH $1.18
  • P/E Ratio
  • PHAR N/A
  • CYH N/A
  • Revenue Growth
  • PHAR 30.64
  • CYH 0.81
  • 52 Week Low
  • PHAR $6.65
  • CYH $2.51
  • 52 Week High
  • PHAR $13.20
  • CYH $6.29
  • Technical
  • Relative Strength Index (RSI)
  • PHAR 52.85
  • CYH 36.59
  • Support Level
  • PHAR $9.37
  • CYH $2.85
  • Resistance Level
  • PHAR $10.15
  • CYH $3.04
  • Average True Range (ATR)
  • PHAR 0.48
  • CYH 0.12
  • MACD
  • PHAR -0.11
  • CYH 0.03
  • Stochastic Oscillator
  • PHAR 27.46
  • CYH 34.38

About PHAR Pharming Group N.V.

Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.

About CYH Community Health Systems Inc.

Community Health Systems Inc is a publicly owned hospital operator in the United States. The company also owns four home health agencies and provides management and consulting services to independent hospitals. The firm derives revenue through a broad range of general and specialized hospital healthcare services and outpatient services.

Share on Social Networks: